Skip to main content

Table 1 Patient characteristics

From: Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study

Patient

Age,

years

Sex

weight (kg)

Age of onset (y)

Epilepsy diagnosis (localization)

AEDs

Seizure frequency

Seizure Types

Etiology

1

17

M

53.6

6

FE (L-F)

LTG, VPA, and ZNS

Yearly

Versive seizure

–

2

10

M

35.5

5

FE (R-O)

CLB, VPA, SLM, and PER

Daily

CPS, SPS

Ulegyria

3

22

M

68.3

19

FE (R-T)

LEV

Monthly

CPS

Tumor (low grade glioma)

4

6

M

34.9

4

FE (R-F)

–

Monthly

Versive seizure

Autoimmune encephalitis

5

14

F

53.7

9

FE (R-T)

LEV and CBZ

Daily

CPS

Hippocampal sclerosis

6

4

M

15.1

0.5

WS

VPA, ZNS, ESM, and LTG

Daily

Tonic seizure, epileptic spasms

TSC

7

3

F

18.8

0.3

WS

VGB, VPA, LEV, and GBP

Daily

Tonic seizure, epileptic spasms

TSC

8

3

M

14.7

0.6

FE (L-F)

PB and LTG

Daily

hypermotor seizure

TSC2 mutation

9

13

F

29.0

0.2

FE (R-F)

LTG, VPA, AZA, LCM

Weekly

sGTC

1p36 deletion

10

9

M

24.7

5

WS

VPA and LTG

Daily

Tonic seizure, epileptic spasms

TSC

11

11

M

38.1

6

FE (L-O)

CBZ, PB, and PER

Daily/weekly

Visual SPS/sGTC

Cerebral infarction

12

16

F

47.5

3

FE (R-F)

LEV, LTG, CLB, and PER

Monthly

SPS

Cavernous hemangioma

13

25

M

48.0

0.5

FE (R-F)

TPM, CLB, LEV, and PER

Yearly

sGTC

Sturge-Weber syndrome

14

8

M

23.0

4

FE (L-F)

ZNS and CBZ

Daily

Automatism

–

15

5

M

18.6

3

FE (L-T)

PB and CZP

Daily

Epileptic spasms, CPS

Herpes encephalitis

16

11

M

35.9

7

FE (LR-F)

LTG and CBZ

Weekly

Versive seizure

–

17

16

F

43.9

4

FE (R-F)

VPA

Daily

Hypermotor seizure

TSC

18

11

M

33.7

1.6

FE (R-F)

CBZ and VPA

–

Versive seizure

TSC

19

10

M

58.5

5

LK

CZP, ESM, LCM, DZP, and VPA

Yearly

CPS

–

20

7

F

20.1

1.5

FE (LR-F)

VPA, PHT, and ZNS

Daily

Hypermotor seizure

–

21

22

F

42.0

2.3

FE (R-F)

PHT, VPA, LTG, and PER

Monthly

SPS

TSC

22

13

M

29.1

3.4

FE (L-P)

LTG, ZNS, and VPA

Daily

Hypermotor, tonic

FCD

23

19

M

61.5

13

FE (L-T)

CBZ and PER

Yearly

Visual aura~sGTC

–

24

11

M

45.6

1.3

FE (L-F)

LEV, SLM, and NZP

Weekly

brief tonic (CPS)

–

25

6

F

19.6

2.4

FE (R-F)

VPA and PER

–

subclinical seizure only

TSC

26

1

F

8.6

0.8

WS

VGB

Daily

epileptic spasms

HME+FCD

27

13

F

53.8

5.4

FE (L-F)

TPM, LEV, PER, and LTG

Weekly

SPS

–

  1. AEDs antiepileptic drugs, F Female, M male, FE focal epilepsies, L- left, R- right, F frontal, T temporal, O occipital, P parietal, WS West syndrome, LK Landau-Kleffner syndrome, LTG lamotrigine, VPA valproic acid, ZNS zonisamide, CLB clobazam, SLM sultiam, PER perampanel, LEV levetiracetam, CBZ carbamazepine, ESM ethosuximide, VGB vigabatrin, GBP gabapentin, PB phenobarbital, AZA acetazolamide, LCM lacosamide, TPM topiramate, DZP diazepam, PHT phenytoin, CPS complex partial seizures, SPS simple partial seizures, sGTC secondarily generalized tonic–clonic convulsion, TSC tuberous sclerosis complex, FCD focal cortical dysplasias, HME hemimegalencephaly